Organoid Study Reveals How WNT2B Mutations Drive Deadly Congenital Diarrhea

A rare and devastating genetic condition known as Diarrhea-9 has long frustrated scientists trying to understand exactly how it destroys the newborn intestine. Mutations in a gene called WNT2B, which encodes a key member of the Wnt signaling family, produce a congenital diarrhea syndrome with an extreme clinical phenotype and distinctive histological defects that no laboratory animal model has managed to reproduce faithfully. Now, a team of researchers working across Cincinnati Children’s Hospital Medical Center, Boston Children’s Hospital, Johns Hopkins University School of Medicine and partner institutions has turned to human intestinal organoids, lab-grown miniature guts derived from stem cells, to dissect the disease at a level of detail previously impossible. Their findings, published in BMC Biology, reveal that WNT2B acts in a compartment-specific manner, with the connective tissue compartment known as the mesenchyme exerting a particularly powerful influence over the architecture and organization of the intestinal lining.

The clinical stakes could hardly be higher. Congenital diarrheas and enteropathies are a group of inherited disorders that strike in the first weeks or months of life, often leaving infants dependent on intravenous nutrition and, in the most severe cases, candidates for intestinal transplantation. Diarrhea-9, caused by loss-of-function mutations in WNT2B, is among the most extreme of these conditions. Yet attempts to model the disease in rodents have fallen short, and studying epithelial tissue taken directly from patients has not fully captured the human phenotype. This gap between mouse and human biology is precisely what the new study set out to close by building the disease in a dish, using human cells that carry the very mutation found in patients.

The research team generated induced pluripotent stem cells from a patient carrying a specific nonsense mutation in WNT2B, designated WNT2B R69*, a single DNA base change that introduces a premature stop signal and truncates the protein. These patient-derived stem cells were then coaxed through the elaborate choreography of intestinal development, first into definitive endoderm and ultimately into three-dimensional human intestinal organoids, or HIOs, which contain both the epithelial lining of the gut and its surrounding mesenchymal support tissue. Quality-control assays, including karyotyping, STR profiling and pluripotency scorecard testing, confirmed that the patient-derived line behaved like a healthy stem cell line in every respect except the one under investigation: the WNT2B mutation itself.

When the researchers examined the WNT2B-deficient organoids under live and histological imaging, a striking abnormality emerged. The organoids showed partial epithelial delamination, meaning that cells of the intestinal lining were detaching and peeling away from their proper positions, a defect entirely absent in control organoids derived from healthy stem cells. Delamination of the epithelium is a catastrophic problem for an organ whose function depends on an intact, continuous barrier between the body and the outside world. It provides a direct structural explanation for the severe malabsorption and fluid loss that characterize Diarrhea-9 in affected infants.

The damage extended deep into the regenerative engine of the intestine. A significant fraction of the crypt-like structures in WNT2B-deficient organoids lacked olfactomedin 4, or OLFM4, a well-established surrogate marker of active intestinal stem cell function. Because the intestinal lining turns over every few days in healthy tissue, sustained stem cell activity is essential for maintaining the barrier. The loss of OLFM4 signal suggests that WNT2B deficiency undermines the stem cell compartment, potentially compounding the structural defects with a failure of repair and renewal. Further characterization of secretory lineages, including Paneth cells marked by lysozyme, goblet cells marked by mucin 2, and enteroendocrine cells marked by chromogranin A, allowed the team to assess whether specific differentiated cell types were selectively lost, painting a detailed cellular census of the diseased tissue.

Beyond structure, the study probed function at the molecular level. Transcriptomic analysis comparing WNT2B-deficient and control organoids identified a set of significantly altered biological pathways, among the most notable being the trafficking of apical digestion proteins, the molecular machinery that delivers digestive enzymes such as sucrase isomaltase to the microvillar surface of the epithelium where nutrients are absorbed. Immunofluorescence staining confirmed these transcriptional findings visually, showing mislocalized digestion machinery in the mutant tissue. Proteomic analysis of enteroids derived from the patient’s own tissue revealed a broadly similar pattern of disruption, providing independent lines of evidence that WNT2B loss derails both the logistics of digestion and the integrity of the epithelial barrier. Additional analyses of epithelial junction and barrier-associated genes, including tight junction components, adherens junction genes and epithelial keratins, further mapped the molecular consequences of the mutation.

Perhaps the most conceptually important experiment involved organoid recombination, a technique that allowed the researchers to build chimeric organoids with mixed origins: normal epithelium paired with WNT2B-deficient mesenchyme, or mutant epithelium paired with normal mesenchyme. The results were unambiguous. When the mesenchyme lacked WNT2B, the resulting organoids showed a far more pronounced disruption of epithelial architecture and organization than when the epithelium itself carried the defect. In other words, the surrounding connective tissue compartment, not the lining cells alone, is the dominant driver of the structural collapse seen in Diarrhea-9. This finding reframes the disease as a disorder of the gut’s supporting niche as much as of its absorptive surface.

This compartment-specific conclusion carries broad implications for developmental biology. Wnt signaling is one of the fundamental patterning systems of the animal body, and WNT2B is expressed in the mesenchyme underlying the intestinal epithelium, where it has been suspected of nurturing stem cells and organizing tissue architecture. The new data demonstrate that in humans, the mesenchymal source of WNT2B is not a redundant backup but a critical instructive signal for the epithelium. They also help explain why mouse models have failed to capture the human disease: the division of labor between epithelial and mesenchymal Wnt sources appears to differ between species, making human organoid systems not merely convenient but essential for studying this condition.

The study also delivers a methodological message that resonates well beyond Diarrhea-9. Human intestinal organoids, and in particular transplanted human intestinal organoids that mature in vivo and can later be harvested as enteroids for functional experiments, proved capable of reproducing a human-specific intestinal disorder that rodents could not. Functional assays on enteroids derived from the organoids, including responses to forskolin that trigger fluid secretion, demonstrated that the model system supports physiological testing, not just static observation. As organoid platforms proliferate across biomedical research, this work stands as a case study in how patient-derived stem cells can illuminate rare diseases that have resisted conventional modeling for decades.

For families affected by congenital diarrheas, the research offers a clearer mechanistic map of what has gone wrong and a credible experimental platform for testing future interventions. By pinpointing the mesenchyme as the critical compartment and identifying stem cell exhaustion, epithelial delamination and defective trafficking of digestive proteins as downstream consequences of WNT2B loss, the study defines concrete targets for therapy development, whether through small molecules that bolster epithelial resilience, niche-supporting factors that substitute for missing Wnt signals, or gene-based approaches that correct the underlying mutation. It also underscores the value of international collaboration among pediatric hospitals, stem cell facilities and proteomics cores in tackling diseases so rare that no single institution could assemble the evidence alone. As the organoid revolution matures, studies of this kind are transforming rare genetic disorders from unsolvable mysteries into tractable engineering problems, one miniature human gut at a time.

Subject of Research: Compartment-specific roles of the WNT2B signaling gene in human intestinal development and congenital diarrhea

Article Title: Compartment-specific roles for WNT2B in human intestinal development and function

Article References: Compartment-specific roles for WNT2B in human intestinal development and function. (n.d.). https://doi.org/10.1186/s12915-026-02724-2

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02724-2

Keywords: WNT2B, congenital diarrhea, human intestinal organoids, intestinal stem cells, mesenchyme, epithelium, Diarrhea-9, organoid recombination, BMC Biology, developmental biology, enteroids, rare disease